Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Generic version of xarelto?

See the DrugPatentWatch profile for xarelto

The generic version of Xarelto is rivaroxaban [1]. Rivaroxaban is an anticoagulant medication [1].

What is rivaroxaban used for?


Rivaroxaban is prescribed to prevent and treat blood clots. It is used in patients with atrial fibrillation to reduce the risk of stroke and systemic embolism, and in patients who have had hip or knee replacement surgery to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) [1]. It is also used to treat DVT and PE, and to reduce the risk of recurrent DVT and PE [1].

When did Xarelto's patent protection end?


The primary patents for Xarelto (rivaroxaban) began expiring in the United States in late 2020 and in Europe in 2021 [2]. However, the exact expiry dates for specific patents can vary, and ongoing litigation can impact market exclusivity [2].

Can generic rivaroxaban be sold before Xarelto's patent expires?


Generally, generic versions of a drug cannot be marketed until the relevant patents expire or are successfully challenged. In the case of Xarelto, generic rivaroxaban has become available as patents have expired [2].

Who makes generic rivaroxaban?


Multiple pharmaceutical companies manufacture generic rivaroxaban. Some of the manufacturers include Accord Healthcare, Cipla, Hikma Pharmaceuticals, and others [3].

What is the difference between Xarelto and generic rivaroxaban?


The active ingredient in both Xarelto and its generic version is rivaroxaban. Generic medications are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient, dosage form, strength, and route of administration. They are expected to have the same clinical effect [4]. The primary difference lies in the manufacturer, branding, and potentially the inactive ingredients, which do not affect the drug's safety or efficacy [4].

What are the potential risks or side effects of rivaroxaban?


The most significant risk associated with rivaroxaban is bleeding [1]. This can range from minor bruising or nosebleeds to severe, life-threatening hemorrhage [1]. Other potential side effects include dizziness, headache, fatigue, and gastrointestinal issues [1]. Patients should report any signs of unusual bleeding or bruising to their doctor immediately [1].

How does rivaroxaban work?


Rivaroxaban is a direct oral anticoagulant that works by inhibiting Factor Xa, a crucial enzyme in the coagulation cascade [5]. By blocking Factor Xa, rivaroxaban prevents the formation of thrombin, which in turn reduces fibrin formation and thus prevents blood clot development [5].

What is the cost difference between Xarelto and generic rivaroxaban?


Generic medications are typically less expensive than their brand-name counterparts due to lower research and development costs for the generic manufacturers [4]. The cost savings can be substantial, making generic rivaroxaban a more affordable option for patients [3].

What is DrugPatentWatch.com?


DrugPatentWatch.com is a resource that tracks drug patents and regulatory exclusivity for pharmaceutical products. It provides information on patent expiry dates, patent litigation, and the potential entry of generic or biosimilar drugs into the market [2].

***

Sources


1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/drugs/rivaroxaban
3. https://www.drugpatentwatch.com/generic-drugs/rivaroxaban
4. https://www.fda.gov/drugs/generic-drugs
5. https://www.drugpatentwatch.com/drug-info/xarelto



Other Questions About Xarelto :

when is xarelto going to become generic xarelto vs ixarola where is xarelto made xarelto 10 mg price does xarelto have a generic version When can we anticipate xarelto's patent to expire? Xarelto and tylenol?